BioCentury This Week is hosted by Washington Editor Steve Usdin and Publisher Eric Pierce, both 19 year veterans of BioCentury. They are supported by BioCentury's network of senior scientific and business editors recognized for their deep knowledge and understanding of biotechnology: its science, its history and its players.

BioCentury This Week programming is overseen by BioCentury's founders, Chairman & Editor-in-Chief Karen Bernstein, Ph.D., and President & CEO David Flores, both globally recognized for their efforts to provide an objective, accurate and authoritative information platform for key decision makers in bioindustry.




Steve Usdin is BioCentury's original Washington Editor. He has devoted more than 20 years to covering political and policy issues affecting the life sciences sector, and has earned the reputation as the industry's most respected writer/analyst on public policy, regulatory reform and regulatory innovation.



Eric Pierce joined BioCentury in 1993, quickly becoming the company's chief financial writer. He originated "Ebb & Flow," BioCentury's weekly capital markets report. Eric also served as Senior Editor for News, managing BioCentury's news operations. In 2007, he was named Publisher and is responsible for BioCentury's conferences and business services.






David has devoted more than 20 years developing information products for biotechnology executives and investors. He is a graduate of the University of California at Berkeley and holds an MBA from Stanford University.

David is a member of the Advisory Board of the Innovation and New Ventures Office (INVO) at Northwestern University and a member of the Advisory Council of the Keck Graduate Institute of the Applied Life Sciences.

He also has served as a member of the Stanford Graduate School of Business Management Board. In 1996, David and BioCentury Co-Founder, Chairman & Editor-in-Chief Karen Bernstein were honored with the Special Recognition Award given by the annual gathering of biotechnology chief executive officers in Laguna Niguel, California, citing BioCentury's ongoing contributions to the industry.



Karen has been writing and publishing on biotechnology since 1987. She holds a Ph.D. in political science from Stanford University, and a B.A. in politics and history from Brandeis University, where she now is a member of the Brandeis University Science Advisory Council.

She also is on the board of trustees of the Keck Graduate Institute. In 1996, Karen and Co-Founder, President & CEO David Flores were honored with the Special Recognition Award given by the annual gathering of biotechnology chief executive officers at The Biotech Meeting in Laguna Niguel, California, citing BioCentury's ongoing contributions to the industry.

In 2005, The Biotech Meeting CEOs inducted Karen into their Hall of Fame, citing her lifetime contribution to the biotech community. In 2007, Karen received a Special Recognition award at the American Liver Foundation's Salute to Excellence, honoring individuals who have made an outstanding contribution to biotechnology and medical innovation.